The Main Immune Markers of Ligamentum Flavum Hypertrophy: A Narrative Literature Review

LF hypertrophy contributes to the narrowing and compression of neural structures, impairing limb function. It is a leading cause of spinal stenosis, particularly in the lumbar region. About 20% of those over 60 show lumbar stenosis on imaging, but over 80% have no symptoms. Surgery is the main treatment option and is only recommended for symptomatic cases. The exact cause of LF hypertrophy remains unclear, though chronic inflammation, fibrosis and oxidative stress are implicated. Research consistently shows that increased cytokines and growth factors drive extracellular matrix remodeling, immune cell infiltration, and fibroblast and osteoblast activation. The aim of this article is to briefly review the role of the main immune markers that are involved in the pathogenesis of LF hypertrophy. This narrative review is based on a PubMed literature search and includes 23 original articles published between 2019 and 2026.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-07-27
DOI
https://doi.org/10.3390/ijms27156690
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Main Immune Markers of Ligamentum Flavum Hypertrophy: A Narrative Literature Review

Laura Tamašauskienė, Domantas Tamašauskas, Brigita Gradauskienė
International Journal of Molecular Sciences
Spine and Intervertebral Disc Pathology
article

The Main Immune Markers of Ligamentum Flavum Hypertrophy: A Narrative Literature Review

Laura Tamašauskienė, Domantas Tamašauskas, Brigita Gradauskienė
article en

Abstract

LF hypertrophy contributes to the narrowing and compression of neural structures, impairing limb function. It is a leading cause of spinal stenosis, particularly in the lumbar region. About 20% of those over 60 show lumbar stenosis on imaging, but over 80% have no symptoms. Surgery is the main treatment option and is only recommended for symptomatic cases. The exact cause of LF hypertrophy remains unclear, though chronic inflammation, fibrosis and oxidative stress are implicated. Research consistently shows that increased cytokines and growth factors drive extracellular matrix remodeling, immune cell infiltration, and fibroblast and osteoblast activation. The aim of this article is to briefly review the role of the main immune markers that are involved in the pathogenesis of LF hypertrophy. This narrative review is based on a PubMed literature search and includes 23 original articles published between 2019 and 2026.

International Journal of Molecular SciencesVol. 27(15)
Lithuanian University of Health Sciences (LT)
Good health and well-being
Openalex Percentile: Top 9%
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.